Relevant non-pharmacologic topics for clinical research in rheumatic musculoskeletal diseases: The patient perspective.
diet
emotional well-being
environment
participation
patient perspective
patient-physician relation
research
rheumatic musculoskeletal diseases
work ability
Journal
International journal of rheumatic diseases
ISSN: 1756-185X
Titre abrégé: Int J Rheum Dis
Pays: England
ID NLM: 101474930
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
19
03
2020
revised:
03
07
2020
accepted:
13
07
2020
pubmed:
7
8
2020
medline:
3
11
2021
entrez:
7
8
2020
Statut:
ppublish
Résumé
The research approach on rheumatic musculoskeletal diseases (RMDs) is challenging and patient involvement is an emerging issue to obtain relevant information to research. Despite growing interest in non-pharmacologic aspects of clinical research in RMDs, the patients' perspectives are currently poorly explored. A cross-sectional no-profit online survey was devised to identify and rank the priorities for clinical research in RMDs according to patients' perspectives. Patients were asked to rate the following topics: food/nutrition, air pollution, smoking, work activity, social participation, physical activity, emotional well-being/stress, alternative medicine, and patient-physician relationship. The survey was disseminated by ALOMAR (Lombard Association for Rheumatic Diseases) between June and October 2019. Two hundred RMD patients completed the survey. The topic most rated 188 (94%) was the doctor-patient relationship, considered very or extremely important. Other topics rated as follows: psychological well-being 185 (92.5%), physical activity 155 (77.5%), nutrition, eating habits 150 (75%), alternative therapies 144 (72%), work activity 144 (72%), environmental pollution 134 (67%), social life 121 (60.5%) and cigarette smoke 119 (59.5%). The topics considered relevant were perceived to be able to influence disease symptoms. Environmental pollution and smoking were considered the most important for RMD prevention in 43.3% and 48.7% respectively. This survey highlights the relevance of several unmet needs and indicates that active patient involvement is essential to design successful translational studies and improve clinical outcomes.
Identifiants
pubmed: 32757261
doi: 10.1111/1756-185X.13932
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1305-1310Informations de copyright
© 2020 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.
Références
Moradi-Lakeh M, Forouzanfar MH, Vollset SE, et al. Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013. Ann Rheum Dis. 2017;76(8):1365-1373.
Locock L, Boylan AM, Snow R, Staniszewska S. The power of symbolic capital in patient and public involvement in health research. Health Expect. 2017;20(5):836-844.
Chu LF, Utengen A, Kadry B, et al. "Nothing about us without us"-patient partnership in medical conferences. BMJ. 2016;354:i3883.
Johnson DS, Bush MT, Brandzel S, Wernli KJ. The patient voice in research-evolution of a role. Res Involve Engag. 2016;2:6.
Brett JO, Staniszewska S, Mockford C, et al. Mapping the impact of patient and public involvement on health and social care research: a systematic review. Health Expect. 2014;17(5):637-650.
Clancy C, Collins FS. Patient-Centered Outcomes Research Institute: the intersection of science and health care. Sci Transl Med. 2010;2(37):37cm18.
Forsythe LP, Carman KL, Szydlowski V, et al. Patient engagement in research: early findings from the Patient-Centered Outcomes Research Institute. Health Aff. 2019;38(3):359-367.
Tugwell P, Boers M. OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction. The Journal of rheumatology. 1993;20(3):528-530.
Barr PJ, Elwyn G. Measurement challenges in shared decision making: putting the 'patient' in patient-reported measures. Health Expect. 2016;19(5):993-1001.
Sacristan JA, Aguaron A, Avendaño C, et al. Patient involvement in clinical research: why, when, and how. Patient Prefer Adherence. 2016;10:631-640.
Kirwan JR, Hewlett SE, Heiberg T, et al. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis-progress at OMERACT 7. J Rheumatol. 2005;32(11):2250-2256.
Food Drug Administration. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims, 2009. [updated Accessed 12 Jan 2017] http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.%5D
European Medicines Agency. Draft guideline on clinical investigation of medicinal products other than NSAIDs for treatment of rheumatoid arthritis, 2015. [updated Accessed 20 Apr 2017] http://www.ema.europa.eu/docs/en_GB/document_library/Scientificguideline/2015/06/WC500187583.pdf.%5D
Singh JA. Research priorities in gout: the patient perspective. J Rheumatol. 2014;41(3):615-616.
Staniszewska S, Brett J, Simera I, et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. Res Involve Engag. 2017;3:13.
Gautam S, Tolahunase M, Kumar U, Dada R. Impact of yoga based mind-body intervention on systemic inflammatory markers and co-morbid depression in active rheumatoid arthritis patients: a randomized controlled trial. Rest Neurol Neurosci. 2019;37(1):41-59.
Lin C-T, Albertson GA, Schilling LM, et al. Is patients' perception of time spent with the physician a determinant of ambulatory patient satisfaction? Arch Intern Med. 2001;161(11):1437-1442.
Ryan S, Hassell A, Dawes P, Kendall S. Control perceptions in patients with rheumatoid arthritis: the impact of the medical consultation. Rheumatology. 2003;42(1):135-140.
Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960-977.
de Souza S, Williams R, Lempp H. Patient and clinician views on the quality of foot health care for rheumatoid arthritis outpatients: a mixed methods service evaluation. J Foot Ankle Res. 2016;9:1.
Zulman DM, Haverfield MC, Shaw JG, et al. Practices to foster physician presence and connection with patients in the clinical encounter. JAMA. 2020;323(1):70-81.
Hojat M, Shannon SC, DeSantis J, et al. Does empathy decline in the clinical phase of medical education? a nationwide, multi-institutional, cross-sectional study of students at DO-Granting Medical Schools. Acad Med. 2020;95(6):911-918.
Studenic P, Smolen JS, Aletaha D. Near misses of ACR/EULAR criteria for remission: effects of patient global assessment in Boolean and index-based definitions. Ann Rheum Dis. 2012;71(10):1702-1705.
Leung YY, Li JC, Thumboo J. Domains rated as important by patients with hand osteoarthritis. Int J Rheum Dis. 2019;22(11):2045-2051.
Leonardo N, Lester S, Graham M, et al. Selection and perception of methotrexate treatment information in people with rheumatoid arthritis. Int J Rheum Dis. 2020;23(6):805-812.
Rausch Osthoff A-K, Niedermann K, Braun J, et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018;77(9):1251-1260.
Ferreira RJO, Ndosi M, de Wit M, et al. Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis. Ann Rheum Dis. 2019;78(10):e109.
Nowicka-Sauer K, Pietrzykowska M, Banaszkiewicz D, et al. How do patients and doctors-to-be perceive systemic lupus erythematosus? Rheumatol Int. 2016;36(5):725-729.
Lloyd K, White J. Democratizing clinical research. Nature. 2011;474(7351):277-278.
van der Scheer L, Garcia E, van der Laan AL, van der Burg S, Boenink M. The benefits of patient involvement for translational research. Health Care Anal. 2017;25(3):225-241.
Moses N, Wiggers J, Nicholas C, Cockburn J. Prevalence and correlates of perceived unmet needs of people with systemic lupus erythematosus. Patient Educ Couns. 2005;57(1):30-38.
Grainger R, Townsley HR, Ferguson CA, et al. Patient and clinician views on an app for rheumatoid arthritis disease monitoring: Function, implementation and implications. Int J Rheum Dis. 2020;23(6):813-827.
Ogdie A, Asch DA. Changing health behaviours in rheumatology: an introduction to behavioural economics. Nat Rev Rheumatol. 2020;16(1):53-60.